Speed Medical Co マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Hazem Farouq Kamal Al-Far

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	0.006%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

CEO（最高経営責任者

Hazem Farouq Kamal Al-Far

no data

在職期間

Mr. Hazem Farouq Ahmed Kamal Al-Far is Vice Chairman and Managing Director of the Board of Speed Medical Co and served as Financial Director.

Speed Medical Co マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

Speed Medical Co, Annual General Meeting, Jul 04, 2024

No independent directors

No independent directors

Recent updates

Second quarter 2024 earnings released: ج.م0.013 loss per share (vs ج.م0.02 loss in 2Q 2023)

Speed Medical Co, Annual General Meeting, Jul 04, 2024

New minor risk - Shareholder dilution

An Unknown buyer completed the acquisition of 6.01% of stake in Speed Medical Co (CASE:SPMD) from Sherif Alaa Ahmed El-Zayat for EGP 28.9 million.

An Unknown buyer completed the acquisition of 6.01% of stake in Speed Medical Co (CASE:SPMD) from Sherif Alaa Ahmed El-Zayat for EGP 28.9 million.

No independent directors

Unknown Buyer completed the acquisition of 30% stake in Prime Speed Medical Services from Speed Medical Co (CASE:SPMD).

An unknown buyer acquired a 12.55% stake in Speed Medical Co (CASE : SPMD) from Mahmoud Ahmed Mahmoud Lashin for EGP 62.1 million.

Price target decreased to ج.م2.00

No independent directors

Price target decreased to ج.م2.00

Speed Medical Company(CASE:SPMD) dropped from EGX 30 Index

An unknown buyer acquired 7.08% stake from Mahmoud Ahmed Mahmoud Lasheen for EGP 76.94 million.

An unknown buyer acquired 2.976% stake in Speed Medical Company (CASE:SPMD) from Mahmoud Ahmed Mahmoud Lasheen for EGP 49.33 million.

Price target increased to ج.م2.33

Speed Medical Company announced that it expects to receive EGP 1.57 billion in funding from Global Emerging Markets

CEO（最高経営責任者

在職期間

Speed Medical Co マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Speed Medical Co, Annual General Meeting, Jul 04, 2024

No independent directors

No independent directors

Recent updates

Second quarter 2024 earnings released: ج.م0.013 loss per share (vs ج.م0.02 loss in 2Q 2023)

Speed Medical Co, Annual General Meeting, Jul 04, 2024

New minor risk - Shareholder dilution

An Unknown buyer completed the acquisition of 6.01% of stake in Speed Medical Co (CASE:SPMD) from Sherif Alaa Ahmed El-Zayat for EGP 28.9 million.

An Unknown buyer completed the acquisition of 6.01% of stake in Speed Medical Co (CASE:SPMD) from Sherif Alaa Ahmed El-Zayat for EGP 28.9 million.

No independent directors

Unknown Buyer completed the acquisition of 30% stake in Prime Speed Medical Services from Speed Medical Co (CASE:SPMD).

An unknown buyer acquired a 12.55% stake in Speed Medical Co (CASE : SPMD) from Mahmoud Ahmed Mahmoud Lashin for EGP 62.1 million.

Price target decreased to ج.م2.00

No independent directors

Price target decreased to ج.م2.00

Speed Medical Company(CASE:SPMD) dropped from EGX 30 Index

An unknown buyer acquired 7.08% stake from Mahmoud Ahmed Mahmoud Lasheen for EGP 76.94 million.

An unknown buyer acquired 2.976% stake in Speed Medical Company (CASE:SPMD) from Mahmoud Ahmed Mahmoud Lasheen for EGP 49.33 million.

Price target increased to ج.م2.33

Speed Medical Company announced that it expects to receive EGP 1.57 billion in funding from Global Emerging Markets

CEO（最高経営責任者

在職期間

マネジメント基準チェック /04